nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.134	1	CrCrCtD
Doxepin—ADRA2A—type 2 diabetes mellitus	0.0874	0.325	CbGaD
Doxepin—HTR2C—type 2 diabetes mellitus	0.0805	0.299	CbGaD
Doxepin—CYP1A2—type 2 diabetes mellitus	0.0607	0.226	CbGaD
Doxepin—CYP3A4—type 2 diabetes mellitus	0.0402	0.15	CbGaD
Doxepin—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0197	0.0528	CbGbCtD
Doxepin—ORM1—Nateglinide—type 2 diabetes mellitus	0.0183	0.0489	CbGbCtD
Doxepin—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0176	0.0471	CbGbCtD
Doxepin—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0173	0.0462	CbGbCtD
Doxepin—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0157	0.0419	CbGbCtD
Doxepin—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0149	0.0398	CbGbCtD
Doxepin—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0126	0.0336	CbGbCtD
Doxepin—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0115	0.0307	CbGbCtD
Doxepin—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0108	0.0289	CbGbCtD
Doxepin—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0103	0.0277	CbGbCtD
Doxepin—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0103	0.0277	CbGbCtD
Doxepin—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.00991	0.0265	CbGbCtD
Doxepin—DRD2—Bromocriptine—type 2 diabetes mellitus	0.00953	0.0255	CbGbCtD
Doxepin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00824	0.0221	CbGbCtD
Doxepin—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00774	0.0207	CbGbCtD
Doxepin—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00757	0.0203	CbGbCtD
Doxepin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00735	0.0197	CbGbCtD
Doxepin—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00692	0.0185	CbGbCtD
Doxepin—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00658	0.0176	CbGbCtD
Doxepin—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00658	0.0176	CbGbCtD
Doxepin—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00644	0.0172	CbGbCtD
Doxepin—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00608	0.0163	CbGbCtD
Doxepin—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00587	0.0157	CbGbCtD
Doxepin—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00561	0.015	CbGbCtD
Doxepin—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00547	0.0146	CbGbCtD
Doxepin—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00547	0.0146	CbGbCtD
Doxepin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00531	0.0142	CbGbCtD
Doxepin—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00505	0.0135	CbGbCtD
Doxepin—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00501	0.0134	CbGbCtD
Doxepin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00494	0.0132	CbGbCtD
Doxepin—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00488	0.0131	CbGbCtD
Doxepin—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00462	0.0124	CbGbCtD
Doxepin—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00446	0.0119	CbGbCtD
Doxepin—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00441	0.0118	CbGbCtD
Doxepin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0044	0.0118	CbGbCtD
Doxepin—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00417	0.0112	CbGbCtD
Doxepin—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00415	0.0111	CbGbCtD
Doxepin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00403	0.0108	CbGbCtD
Doxepin—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00398	0.0106	CbGbCtD
Doxepin—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00379	0.0101	CbGbCtD
Doxepin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00365	0.00976	CbGbCtD
Doxepin—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00364	0.00973	CbGbCtD
Doxepin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00352	0.00941	CbGbCtD
Doxepin—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00337	0.00902	CbGbCtD
Doxepin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00318	0.00851	CbGbCtD
Doxepin—CYP2C19—Losartan—type 2 diabetes mellitus	0.00308	0.00825	CbGbCtD
Doxepin—CYP1A2—Losartan—type 2 diabetes mellitus	0.00284	0.00761	CbGbCtD
Doxepin—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0028	0.0075	CbGbCtD
Doxepin—ABCB1—Glyburide—type 2 diabetes mellitus	0.00272	0.00727	CbGbCtD
Doxepin—CYP2C9—Losartan—type 2 diabetes mellitus	0.00256	0.00686	CbGbCtD
Doxepin—ABCB1—Losartan—type 2 diabetes mellitus	0.00249	0.00665	CbGbCtD
Doxepin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00241	0.00645	CbGbCtD
Doxepin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00231	0.00619	CbGbCtD
Doxepin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00231	0.00619	CbGbCtD
Doxepin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00219	0.00585	CbGbCtD
Doxepin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00163	0.00436	CbGbCtD
Doxepin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00149	0.00399	CbGbCtD
Doxepin—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00148	0.0908	CbGeAlD
Doxepin—HTR2A—arteriole—type 2 diabetes mellitus	0.00139	0.0856	CbGeAlD
Doxepin—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.000993	0.061	CbGeAlD
Doxepin—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.000888	0.0546	CbGeAlD
Doxepin—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000597	0.0367	CbGeAlD
Doxepin—SLC6A2—nerve—type 2 diabetes mellitus	0.000558	0.0343	CbGeAlD
Doxepin—HTR2A—hindlimb—type 2 diabetes mellitus	0.000552	0.0339	CbGeAlD
Doxepin—DRD2—nerve—type 2 diabetes mellitus	0.000509	0.0313	CbGeAlD
Doxepin—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000506	0.0311	CbGeAlD
Doxepin—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000431	0.0265	CbGeAlD
Doxepin—HRH2—cardiovascular system—type 2 diabetes mellitus	0.000371	0.0228	CbGeAlD
Doxepin—HTR2A—artery—type 2 diabetes mellitus	0.000338	0.0208	CbGeAlD
Doxepin—HTR2A—nerve—type 2 diabetes mellitus	0.000336	0.0206	CbGeAlD
Doxepin—ADRA1B—kidney—type 2 diabetes mellitus	0.000317	0.0195	CbGeAlD
Doxepin—HTR2A—endothelium—type 2 diabetes mellitus	0.000286	0.0176	CbGeAlD
Doxepin—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000243	0.015	CbGeAlD
Doxepin—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000243	0.0149	CbGeAlD
Doxepin—HRH2—liver—type 2 diabetes mellitus	0.000229	0.0141	CbGeAlD
Doxepin—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000221	0.0136	CbGeAlD
Doxepin—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.00022	0.0135	CbGeAlD
Doxepin—DRD2—retina—type 2 diabetes mellitus	0.000211	0.013	CbGeAlD
Doxepin—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.00021	0.0129	CbGeAlD
Doxepin—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000197	0.0121	CbGeAlD
Doxepin—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000194	0.0119	CbGeAlD
Doxepin—CHRM3—kidney—type 2 diabetes mellitus	0.000194	0.0119	CbGeAlD
Doxepin—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000193	0.0119	CbGeAlD
Doxepin—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000191	0.0118	CbGeAlD
Doxepin—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000182	0.0112	CbGeAlD
Doxepin—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000176	0.0108	CbGeAlD
Doxepin—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000175	0.0107	CbGeAlD
Doxepin—ADRA2C—kidney—type 2 diabetes mellitus	0.00017	0.0104	CbGeAlD
Doxepin—ADRA2C—pancreas—type 2 diabetes mellitus	0.000168	0.0104	CbGeAlD
Doxepin—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000165	0.0102	CbGeAlD
Doxepin—ORM1—liver—type 2 diabetes mellitus	0.000161	0.00992	CbGeAlD
Doxepin—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.00016	0.00986	CbGeAlD
Doxepin—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000153	0.0094	CbGeAlD
Doxepin—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000143	0.00878	CbGeAlD
Doxepin—HTR2A—retina—type 2 diabetes mellitus	0.000139	0.00855	CbGeAlD
Doxepin—Promethazine—CALM1—type 2 diabetes mellitus	0.000136	0.0607	CrCbGaD
Doxepin—ADRA2A—pancreas—type 2 diabetes mellitus	0.000134	0.00826	CbGeAlD
Doxepin—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000132	0.0081	CbGeAlD
Doxepin—HRH1—adipose tissue—type 2 diabetes mellitus	0.000124	0.00763	CbGeAlD
Doxepin—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000122	0.0075	CbGeAlD
Doxepin—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000118	0.00723	CbGeAlD
Doxepin—HTR2A—kidney—type 2 diabetes mellitus	0.000115	0.00707	CbGeAlD
Doxepin—CYP2C19—liver—type 2 diabetes mellitus	0.000114	0.007	CbGeAlD
Doxepin—ADRA1A—liver—type 2 diabetes mellitus	0.000112	0.00691	CbGeAlD
Doxepin—ADRA2C—liver—type 2 diabetes mellitus	0.000107	0.00659	CbGeAlD
Doxepin—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000107	0.00655	CbGeAlD
Doxepin—CYP3A4—kidney—type 2 diabetes mellitus	0.000107	0.00655	CbGeAlD
Doxepin—CYP2D6—kidney—type 2 diabetes mellitus	0.000105	0.00644	CbGeAlD
Doxepin—CYP1A2—liver—type 2 diabetes mellitus	9.3e-05	0.00572	CbGeAlD
Doxepin—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	9.18e-05	0.041	CrCbGaD
Doxepin—ABCB1—retina—type 2 diabetes mellitus	9.11e-05	0.0056	CbGeAlD
Doxepin—CYP2C9—liver—type 2 diabetes mellitus	8.83e-05	0.00543	CbGeAlD
Doxepin—Thiothixene—ADRA2A—type 2 diabetes mellitus	8.78e-05	0.0392	CrCbGaD
Doxepin—ABCB1—nephron tubule—type 2 diabetes mellitus	8.58e-05	0.00527	CbGeAlD
Doxepin—Thiothixene—HTR2C—type 2 diabetes mellitus	8.08e-05	0.0361	CrCbGaD
Doxepin—ABCB1—cardiovascular system—type 2 diabetes mellitus	7.71e-05	0.00474	CbGeAlD
Doxepin—ABCB1—kidney—type 2 diabetes mellitus	7.54e-05	0.00463	CbGeAlD
Doxepin—ABCB1—pancreas—type 2 diabetes mellitus	7.49e-05	0.0046	CbGeAlD
Doxepin—ABCB1—cortex of kidney—type 2 diabetes mellitus	7.34e-05	0.00451	CbGeAlD
Doxepin—HTR2A—liver—type 2 diabetes mellitus	7.27e-05	0.00447	CbGeAlD
Doxepin—Olopatadine—CYP3A4—type 2 diabetes mellitus	7.23e-05	0.0323	CrCbGaD
Doxepin—Clomipramine—ADRA2A—type 2 diabetes mellitus	6.94e-05	0.031	CrCbGaD
Doxepin—ABCB1—adipose tissue—type 2 diabetes mellitus	6.79e-05	0.00418	CbGeAlD
Doxepin—CYP3A4—liver—type 2 diabetes mellitus	6.73e-05	0.00414	CbGeAlD
Doxepin—CYP2D6—liver—type 2 diabetes mellitus	6.62e-05	0.00407	CbGeAlD
Doxepin—Alimemazine—CYP3A4—type 2 diabetes mellitus	6.6e-05	0.0295	CrCbGaD
Doxepin—Clomipramine—HTR2C—type 2 diabetes mellitus	6.39e-05	0.0286	CrCbGaD
Doxepin—Trimipramine—ADRA2A—type 2 diabetes mellitus	6.39e-05	0.0285	CrCbGaD
Doxepin—Chlorprothixene—HTR2C—type 2 diabetes mellitus	6.36e-05	0.0284	CrCbGaD
Doxepin—Nortriptyline—HTR2C—type 2 diabetes mellitus	6.25e-05	0.0279	CrCbGaD
Doxepin—Thiothixene—CYP1A2—type 2 diabetes mellitus	6.1e-05	0.0273	CrCbGaD
Doxepin—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	6.08e-05	0.0272	CrCbGaD
Doxepin—Trimipramine—HTR2C—type 2 diabetes mellitus	5.88e-05	0.0263	CrCbGaD
Doxepin—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	5.56e-05	0.0248	CrCbGaD
Doxepin—Promazine—ADRA2A—type 2 diabetes mellitus	5.41e-05	0.0242	CrCbGaD
Doxepin—Desipramine—HTR2C—type 2 diabetes mellitus	5.14e-05	0.023	CrCbGaD
Doxepin—Promazine—HTR2C—type 2 diabetes mellitus	4.98e-05	0.0223	CrCbGaD
Doxepin—Nortriptyline—CYP2E1—type 2 diabetes mellitus	4.95e-05	0.0221	CrCbGaD
Doxepin—Oxcarbazepine—ALB—type 2 diabetes mellitus	4.85e-05	0.0217	CrCbGaD
Doxepin—Clomipramine—CYP1A2—type 2 diabetes mellitus	4.82e-05	0.0215	CrCbGaD
Doxepin—ABCB1—liver—type 2 diabetes mellitus	4.77e-05	0.00293	CbGeAlD
Doxepin—Nortriptyline—CYP1A2—type 2 diabetes mellitus	4.71e-05	0.0211	CrCbGaD
Doxepin—Amitriptyline—ADRA2A—type 2 diabetes mellitus	4.71e-05	0.021	CrCbGaD
Doxepin—Anxiety—Irbesartan—type 2 diabetes mellitus	4.62e-05	0.000371	CcSEcCtD
Doxepin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.62e-05	0.000371	CcSEcCtD
Doxepin—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.62e-05	0.000371	CcSEcCtD
Doxepin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.61e-05	0.000371	CcSEcCtD
Doxepin—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.61e-05	0.000371	CcSEcCtD
Doxepin—Vertigo—Losartan—type 2 diabetes mellitus	4.61e-05	0.00037	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.61e-05	0.00037	CcSEcCtD
Doxepin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.6e-05	0.00037	CcSEcCtD
Doxepin—Somnolence—Valsartan—type 2 diabetes mellitus	4.6e-05	0.000369	CcSEcCtD
Doxepin—Syncope—Losartan—type 2 diabetes mellitus	4.6e-05	0.000369	CcSEcCtD
Doxepin—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.59e-05	0.000369	CcSEcCtD
Doxepin—Leukopenia—Losartan—type 2 diabetes mellitus	4.59e-05	0.000369	CcSEcCtD
Doxepin—Discomfort—Irbesartan—type 2 diabetes mellitus	4.58e-05	0.000368	CcSEcCtD
Doxepin—Skin disorder—Metformin—type 2 diabetes mellitus	4.58e-05	0.000368	CcSEcCtD
Doxepin—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.56e-05	0.000366	CcSEcCtD
Doxepin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.55e-05	0.000366	CcSEcCtD
Doxepin—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.55e-05	0.000366	CcSEcCtD
Doxepin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000366	CcSEcCtD
Doxepin—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.54e-05	0.000364	CcSEcCtD
Doxepin—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.54e-05	0.000364	CcSEcCtD
Doxepin—Palpitations—Losartan—type 2 diabetes mellitus	4.53e-05	0.000364	CcSEcCtD
Doxepin—Nausea—Glimepiride—type 2 diabetes mellitus	4.52e-05	0.000363	CcSEcCtD
Doxepin—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000362	CcSEcCtD
Doxepin—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.51e-05	0.000362	CcSEcCtD
Doxepin—Nausea—Sitagliptin—type 2 diabetes mellitus	4.5e-05	0.000362	CcSEcCtD
Doxepin—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.5e-05	0.000361	CcSEcCtD
Doxepin—Asthenia—Glyburide—type 2 diabetes mellitus	4.5e-05	0.000361	CcSEcCtD
Doxepin—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.5e-05	0.000361	CcSEcCtD
Doxepin—Anorexia—Metformin—type 2 diabetes mellitus	4.49e-05	0.000361	CcSEcCtD
Doxepin—Cough—Losartan—type 2 diabetes mellitus	4.47e-05	0.000359	CcSEcCtD
Doxepin—Urticaria—Gliclazide—type 2 diabetes mellitus	4.47e-05	0.000359	CcSEcCtD
Doxepin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.47e-05	0.000359	CcSEcCtD
Doxepin—Alopecia—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000358	CcSEcCtD
Doxepin—Fatigue—Valsartan—type 2 diabetes mellitus	4.46e-05	0.000358	CcSEcCtD
Doxepin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.45e-05	0.000358	CcSEcCtD
Doxepin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.45e-05	0.000358	CcSEcCtD
Doxepin—Oedema—Irbesartan—type 2 diabetes mellitus	4.45e-05	0.000357	CcSEcCtD
Doxepin—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.44e-05	0.000357	CcSEcCtD
Doxepin—Pruritus—Glyburide—type 2 diabetes mellitus	4.44e-05	0.000356	CcSEcCtD
Doxepin—Mental disorder—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000355	CcSEcCtD
Doxepin—Constipation—Valsartan—type 2 diabetes mellitus	4.42e-05	0.000355	CcSEcCtD
Doxepin—Infection—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000355	CcSEcCtD
Doxepin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.41e-05	0.000355	CcSEcCtD
Doxepin—Fatigue—Orlistat—type 2 diabetes mellitus	4.41e-05	0.000354	CcSEcCtD
Doxepin—Hypotension—Metformin—type 2 diabetes mellitus	4.4e-05	0.000354	CcSEcCtD
Doxepin—Malnutrition—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000353	CcSEcCtD
Doxepin—Erythema—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000353	CcSEcCtD
Doxepin—Shock—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.000351	CcSEcCtD
Doxepin—Pain—Orlistat—type 2 diabetes mellitus	4.37e-05	0.000351	CcSEcCtD
Doxepin—Chest pain—Losartan—type 2 diabetes mellitus	4.37e-05	0.000351	CcSEcCtD
Doxepin—Myalgia—Losartan—type 2 diabetes mellitus	4.37e-05	0.000351	CcSEcCtD
Doxepin—Arthralgia—Losartan—type 2 diabetes mellitus	4.37e-05	0.000351	CcSEcCtD
Doxepin—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.36e-05	0.00035	CcSEcCtD
Doxepin—Imipramine—HTR2C—type 2 diabetes mellitus	4.36e-05	0.0195	CrCbGaD
Doxepin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.00035	CcSEcCtD
Doxepin—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	4.36e-05	0.0195	CrCbGaD
Doxepin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.00035	CcSEcCtD
Doxepin—Anxiety—Losartan—type 2 diabetes mellitus	4.35e-05	0.000349	CcSEcCtD
Doxepin—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.000349	CcSEcCtD
Doxepin—Amitriptyline—HTR2C—type 2 diabetes mellitus	4.33e-05	0.0194	CrCbGaD
Doxepin—Orphenadrine—CYP2E1—type 2 diabetes mellitus	4.33e-05	0.0194	CrCbGaD
Doxepin—Rash—Bromocriptine—type 2 diabetes mellitus	4.33e-05	0.000347	CcSEcCtD
Doxepin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.32e-05	0.000347	CcSEcCtD
Doxepin—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000347	CcSEcCtD
Doxepin—Tension—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000347	CcSEcCtD
Doxepin—Discomfort—Losartan—type 2 diabetes mellitus	4.31e-05	0.000346	CcSEcCtD
Doxepin—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000346	CcSEcCtD
Doxepin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000345	CcSEcCtD
Doxepin—Headache—Bromocriptine—type 2 diabetes mellitus	4.3e-05	0.000345	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.29e-05	0.000345	CcSEcCtD
Doxepin—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.29e-05	0.000345	CcSEcCtD
Doxepin—Nervousness—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000343	CcSEcCtD
Doxepin—Dry mouth—Losartan—type 2 diabetes mellitus	4.27e-05	0.000343	CcSEcCtD
Doxepin—Anorexia—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.00034	CcSEcCtD
Doxepin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.23e-05	0.00034	CcSEcCtD
Doxepin—Paraesthesia—Metformin—type 2 diabetes mellitus	4.23e-05	0.00034	CcSEcCtD
Doxepin—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.23e-05	0.00034	CcSEcCtD
Doxepin—Confusional state—Losartan—type 2 diabetes mellitus	4.22e-05	0.000339	CcSEcCtD
Doxepin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.21e-05	0.000338	CcSEcCtD
Doxepin—Dyspnoea—Metformin—type 2 diabetes mellitus	4.2e-05	0.000337	CcSEcCtD
Doxepin—Somnolence—Metformin—type 2 diabetes mellitus	4.19e-05	0.000336	CcSEcCtD
Doxepin—Oedema—Losartan—type 2 diabetes mellitus	4.18e-05	0.000336	CcSEcCtD
Doxepin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.18e-05	0.000336	CcSEcCtD
Doxepin—Infection—Losartan—type 2 diabetes mellitus	4.16e-05	0.000334	CcSEcCtD
Doxepin—Hypotension—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000334	CcSEcCtD
Doxepin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.15e-05	0.000333	CcSEcCtD
Doxepin—Dyspepsia—Metformin—type 2 diabetes mellitus	4.15e-05	0.000333	CcSEcCtD
Doxepin—Tremor—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000331	CcSEcCtD
Doxepin—Shock—Losartan—type 2 diabetes mellitus	4.12e-05	0.000331	CcSEcCtD
Doxepin—Urticaria—Valsartan—type 2 diabetes mellitus	4.11e-05	0.00033	CcSEcCtD
Doxepin—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.1e-05	0.00033	CcSEcCtD
Doxepin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.1e-05	0.000329	CcSEcCtD
Doxepin—Decreased appetite—Metformin—type 2 diabetes mellitus	4.1e-05	0.000329	CcSEcCtD
Doxepin—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.09e-05	0.000329	CcSEcCtD
Doxepin—Tachycardia—Losartan—type 2 diabetes mellitus	4.08e-05	0.000328	CcSEcCtD
Doxepin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000328	CcSEcCtD
Doxepin—Desipramine—CYP2E1—type 2 diabetes mellitus	4.08e-05	0.0182	CrCbGaD
Doxepin—Nausea—Bromocriptine—type 2 diabetes mellitus	4.07e-05	0.000327	CcSEcCtD
Doxepin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.07e-05	0.000327	CcSEcCtD
Doxepin—Fatigue—Metformin—type 2 diabetes mellitus	4.06e-05	0.000326	CcSEcCtD
Doxepin—Urticaria—Orlistat—type 2 diabetes mellitus	4.06e-05	0.000326	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000325	CcSEcCtD
Doxepin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.05e-05	0.000325	CcSEcCtD
Doxepin—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.04e-05	0.000325	CcSEcCtD
Doxepin—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.04e-05	0.000325	CcSEcCtD
Doxepin—Asthenia—Gliclazide—type 2 diabetes mellitus	4.04e-05	0.000325	CcSEcCtD
Doxepin—Agitation—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000325	CcSEcCtD
Doxepin—Constipation—Metformin—type 2 diabetes mellitus	4.03e-05	0.000324	CcSEcCtD
Doxepin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.000321	CcSEcCtD
Doxepin—Anorexia—Losartan—type 2 diabetes mellitus	3.99e-05	0.00032	CcSEcCtD
Doxepin—Vomiting—Glyburide—type 2 diabetes mellitus	3.99e-05	0.00032	CcSEcCtD
Doxepin—Pruritus—Gliclazide—type 2 diabetes mellitus	3.98e-05	0.00032	CcSEcCtD
Doxepin—Malaise—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000318	CcSEcCtD
Doxepin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.96e-05	0.000318	CcSEcCtD
Doxepin—Rash—Glyburide—type 2 diabetes mellitus	3.95e-05	0.000318	CcSEcCtD
Doxepin—Somnolence—Irbesartan—type 2 diabetes mellitus	3.95e-05	0.000318	CcSEcCtD
Doxepin—Dermatitis—Glyburide—type 2 diabetes mellitus	3.95e-05	0.000317	CcSEcCtD
Doxepin—Vertigo—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000317	CcSEcCtD
Doxepin—Syncope—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000317	CcSEcCtD
Doxepin—Leukopenia—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000316	CcSEcCtD
Doxepin—Headache—Glyburide—type 2 diabetes mellitus	3.93e-05	0.000316	CcSEcCtD
Doxepin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000314	CcSEcCtD
Doxepin—Hypotension—Losartan—type 2 diabetes mellitus	3.91e-05	0.000314	CcSEcCtD
Doxepin—Palpitations—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000312	CcSEcCtD
Doxepin—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.88e-05	0.000312	CcSEcCtD
Doxepin—Desipramine—CYP1A2—type 2 diabetes mellitus	3.88e-05	0.0173	CrCbGaD
Doxepin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.00031	CcSEcCtD
Doxepin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.86e-05	0.00031	CcSEcCtD
Doxepin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.85e-05	0.000309	CcSEcCtD
Doxepin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.85e-05	0.000309	CcSEcCtD
Doxepin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.84e-05	0.000308	CcSEcCtD
Doxepin—Cough—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000308	CcSEcCtD
Doxepin—Fatigue—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.000308	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.81e-05	0.000306	CcSEcCtD
Doxepin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.81e-05	0.000306	CcSEcCtD
Doxepin—Convulsion—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000306	CcSEcCtD
Doxepin—Constipation—Irbesartan—type 2 diabetes mellitus	3.8e-05	0.000305	CcSEcCtD
Doxepin—Pain—Irbesartan—type 2 diabetes mellitus	3.8e-05	0.000305	CcSEcCtD
Doxepin—Insomnia—Losartan—type 2 diabetes mellitus	3.78e-05	0.000304	CcSEcCtD
Doxepin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.77e-05	0.000303	CcSEcCtD
Doxepin—Promazine—CYP1A2—type 2 diabetes mellitus	3.76e-05	0.0168	CrCbGaD
Doxepin—Paraesthesia—Losartan—type 2 diabetes mellitus	3.76e-05	0.000302	CcSEcCtD
Doxepin—Urticaria—Metformin—type 2 diabetes mellitus	3.74e-05	0.000301	CcSEcCtD
Doxepin—Arthralgia—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000301	CcSEcCtD
Doxepin—Myalgia—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000301	CcSEcCtD
Doxepin—Chest pain—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000301	CcSEcCtD
Doxepin—Dyspnoea—Losartan—type 2 diabetes mellitus	3.73e-05	0.0003	CcSEcCtD
Doxepin—Anxiety—Ramipril—type 2 diabetes mellitus	3.73e-05	0.0003	CcSEcCtD
Doxepin—Nausea—Glyburide—type 2 diabetes mellitus	3.73e-05	0.000299	CcSEcCtD
Doxepin—Abdominal pain—Metformin—type 2 diabetes mellitus	3.72e-05	0.000299	CcSEcCtD
Doxepin—Dizziness—Gliclazide—type 2 diabetes mellitus	3.72e-05	0.000299	CcSEcCtD
Doxepin—Somnolence—Losartan—type 2 diabetes mellitus	3.72e-05	0.000299	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000299	CcSEcCtD
Doxepin—Asthenia—Valsartan—type 2 diabetes mellitus	3.71e-05	0.000298	CcSEcCtD
Doxepin—Discomfort—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000297	CcSEcCtD
Doxepin—Dyspepsia—Losartan—type 2 diabetes mellitus	3.68e-05	0.000296	CcSEcCtD
Doxepin—Asthenia—Orlistat—type 2 diabetes mellitus	3.67e-05	0.000295	CcSEcCtD
Doxepin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.66e-05	0.000294	CcSEcCtD
Doxepin—Pruritus—Valsartan—type 2 diabetes mellitus	3.66e-05	0.000294	CcSEcCtD
Doxepin—Dry mouth—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000294	CcSEcCtD
Doxepin—Decreased appetite—Losartan—type 2 diabetes mellitus	3.64e-05	0.000292	CcSEcCtD
Doxepin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000292	CcSEcCtD
Doxepin—Confusional state—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000291	CcSEcCtD
Doxepin—Pruritus—Orlistat—type 2 diabetes mellitus	3.62e-05	0.000291	CcSEcCtD
Doxepin—Fatigue—Losartan—type 2 diabetes mellitus	3.61e-05	0.00029	CcSEcCtD
Doxepin—Oedema—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000288	CcSEcCtD
Doxepin—Vomiting—Gliclazide—type 2 diabetes mellitus	3.58e-05	0.000288	CcSEcCtD
Doxepin—Constipation—Losartan—type 2 diabetes mellitus	3.58e-05	0.000287	CcSEcCtD
Doxepin—Pain—Losartan—type 2 diabetes mellitus	3.58e-05	0.000287	CcSEcCtD
Doxepin—Rash—Gliclazide—type 2 diabetes mellitus	3.55e-05	0.000285	CcSEcCtD
Doxepin—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.55e-05	0.000285	CcSEcCtD
Doxepin—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.54e-05	0.000284	CcSEcCtD
Doxepin—Urticaria—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.000284	CcSEcCtD
Doxepin—Shock—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000284	CcSEcCtD
Doxepin—Headache—Gliclazide—type 2 diabetes mellitus	3.53e-05	0.000283	CcSEcCtD
Doxepin—Thiothixene—ALB—type 2 diabetes mellitus	3.52e-05	0.0157	CrCbGaD
Doxepin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000283	CcSEcCtD
Doxepin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.51e-05	0.000282	CcSEcCtD
Doxepin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.51e-05	0.000282	CcSEcCtD
Doxepin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.51e-05	0.000282	CcSEcCtD
Doxepin—Tachycardia—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000281	CcSEcCtD
Doxepin—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.5e-05	0.000281	CcSEcCtD
Doxepin—Skin disorder—Ramipril—type 2 diabetes mellitus	3.49e-05	0.00028	CcSEcCtD
Doxepin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000279	CcSEcCtD
Doxepin—Imipramine—CYP2E1—type 2 diabetes mellitus	3.46e-05	0.0155	CrCbGaD
Doxepin—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.45e-05	0.000277	CcSEcCtD
Doxepin—Amitriptyline—CYP2E1—type 2 diabetes mellitus	3.44e-05	0.0154	CrCbGaD
Doxepin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.42e-05	0.000275	CcSEcCtD
Doxepin—Dizziness—Valsartan—type 2 diabetes mellitus	3.42e-05	0.000275	CcSEcCtD
Doxepin—Anorexia—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000275	CcSEcCtD
Doxepin—Dizziness—Orlistat—type 2 diabetes mellitus	3.38e-05	0.000272	CcSEcCtD
Doxepin—Asthenia—Metformin—type 2 diabetes mellitus	3.38e-05	0.000272	CcSEcCtD
Doxepin—Hypotension—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000269	CcSEcCtD
Doxepin—Nausea—Gliclazide—type 2 diabetes mellitus	3.34e-05	0.000269	CcSEcCtD
Doxepin—Pruritus—Metformin—type 2 diabetes mellitus	3.33e-05	0.000268	CcSEcCtD
Doxepin—Urticaria—Losartan—type 2 diabetes mellitus	3.32e-05	0.000267	CcSEcCtD
Doxepin—Body temperature increased—Losartan—type 2 diabetes mellitus	3.31e-05	0.000266	CcSEcCtD
Doxepin—Abdominal pain—Losartan—type 2 diabetes mellitus	3.31e-05	0.000266	CcSEcCtD
Doxepin—Imipramine—CYP1A2—type 2 diabetes mellitus	3.29e-05	0.0147	CrCbGaD
Doxepin—Vomiting—Valsartan—type 2 diabetes mellitus	3.29e-05	0.000264	CcSEcCtD
Doxepin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.28e-05	0.000263	CcSEcCtD
Doxepin—Amitriptyline—CYP1A2—type 2 diabetes mellitus	3.27e-05	0.0146	CrCbGaD
Doxepin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000263	CcSEcCtD
Doxepin—Rash—Valsartan—type 2 diabetes mellitus	3.26e-05	0.000262	CcSEcCtD
Doxepin—Dermatitis—Valsartan—type 2 diabetes mellitus	3.26e-05	0.000262	CcSEcCtD
Doxepin—Vomiting—Orlistat—type 2 diabetes mellitus	3.25e-05	0.000261	CcSEcCtD
Doxepin—Insomnia—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000261	CcSEcCtD
Doxepin—Headache—Valsartan—type 2 diabetes mellitus	3.24e-05	0.00026	CcSEcCtD
Doxepin—Diarrhoea—Metformin—type 2 diabetes mellitus	3.22e-05	0.000259	CcSEcCtD
Doxepin—Rash—Orlistat—type 2 diabetes mellitus	3.22e-05	0.000259	CcSEcCtD
Doxepin—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000259	CcSEcCtD
Doxepin—Dermatitis—Orlistat—type 2 diabetes mellitus	3.22e-05	0.000259	CcSEcCtD
Doxepin—Headache—Orlistat—type 2 diabetes mellitus	3.2e-05	0.000257	CcSEcCtD
Doxepin—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000257	CcSEcCtD
Doxepin—Clomipramine—CYP3A4—type 2 diabetes mellitus	3.19e-05	0.0143	CrCbGaD
Doxepin—Asthenia—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.000256	CcSEcCtD
Doxepin—Somnolence—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000256	CcSEcCtD
Doxepin—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000254	CcSEcCtD
Doxepin—Pruritus—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000253	CcSEcCtD
Doxepin—Nortriptyline—CYP3A4—type 2 diabetes mellitus	3.12e-05	0.0139	CrCbGaD
Doxepin—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000251	CcSEcCtD
Doxepin—Dizziness—Metformin—type 2 diabetes mellitus	3.12e-05	0.00025	CcSEcCtD
Doxepin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000249	CcSEcCtD
Doxepin—Fatigue—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000248	CcSEcCtD
Doxepin—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.08e-05	0.000248	CcSEcCtD
Doxepin—Nausea—Valsartan—type 2 diabetes mellitus	3.07e-05	0.000247	CcSEcCtD
Doxepin—Constipation—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000246	CcSEcCtD
Doxepin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.000244	CcSEcCtD
Doxepin—Nausea—Orlistat—type 2 diabetes mellitus	3.04e-05	0.000244	CcSEcCtD
Doxepin—Asthenia—Losartan—type 2 diabetes mellitus	3e-05	0.000241	CcSEcCtD
Doxepin—Vomiting—Metformin—type 2 diabetes mellitus	3e-05	0.000241	CcSEcCtD
Doxepin—Rash—Metformin—type 2 diabetes mellitus	2.97e-05	0.000239	CcSEcCtD
Doxepin—Dermatitis—Metformin—type 2 diabetes mellitus	2.97e-05	0.000238	CcSEcCtD
Doxepin—Pruritus—Losartan—type 2 diabetes mellitus	2.96e-05	0.000238	CcSEcCtD
Doxepin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000237	CcSEcCtD
Doxepin—Headache—Metformin—type 2 diabetes mellitus	2.95e-05	0.000237	CcSEcCtD
Doxepin—Dizziness—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000236	CcSEcCtD
Doxepin—Trimipramine—CYP3A4—type 2 diabetes mellitus	2.94e-05	0.0131	CrCbGaD
Doxepin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000236	CcSEcCtD
Doxepin—Diarrhoea—Losartan—type 2 diabetes mellitus	2.86e-05	0.00023	CcSEcCtD
Doxepin—Urticaria—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000229	CcSEcCtD
Doxepin—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000228	CcSEcCtD
Doxepin—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000228	CcSEcCtD
Doxepin—Vomiting—Irbesartan—type 2 diabetes mellitus	2.83e-05	0.000227	CcSEcCtD
Doxepin—Rash—Irbesartan—type 2 diabetes mellitus	2.8e-05	0.000225	CcSEcCtD
Doxepin—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.8e-05	0.000225	CcSEcCtD
Doxepin—Nausea—Metformin—type 2 diabetes mellitus	2.8e-05	0.000225	CcSEcCtD
Doxepin—Headache—Irbesartan—type 2 diabetes mellitus	2.79e-05	0.000224	CcSEcCtD
Doxepin—Clomipramine—ALB—type 2 diabetes mellitus	2.78e-05	0.0124	CrCbGaD
Doxepin—Dizziness—Losartan—type 2 diabetes mellitus	2.77e-05	0.000222	CcSEcCtD
Doxepin—Orphenadrine—CYP3A4—type 2 diabetes mellitus	2.73e-05	0.0122	CrCbGaD
Doxepin—Nortriptyline—ALB—type 2 diabetes mellitus	2.72e-05	0.0122	CrCbGaD
Doxepin—Vomiting—Losartan—type 2 diabetes mellitus	2.66e-05	0.000214	CcSEcCtD
Doxepin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000212	CcSEcCtD
Doxepin—Nausea—Irbesartan—type 2 diabetes mellitus	2.64e-05	0.000212	CcSEcCtD
Doxepin—Rash—Losartan—type 2 diabetes mellitus	2.64e-05	0.000212	CcSEcCtD
Doxepin—Dermatitis—Losartan—type 2 diabetes mellitus	2.64e-05	0.000212	CcSEcCtD
Doxepin—Headache—Losartan—type 2 diabetes mellitus	2.62e-05	0.000211	CcSEcCtD
Doxepin—Asthenia—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000207	CcSEcCtD
Doxepin—Desipramine—CYP3A4—type 2 diabetes mellitus	2.57e-05	0.0115	CrCbGaD
Doxepin—Pruritus—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000204	CcSEcCtD
Doxepin—Promazine—CYP3A4—type 2 diabetes mellitus	2.49e-05	0.0111	CrCbGaD
Doxepin—Nausea—Losartan—type 2 diabetes mellitus	2.49e-05	0.0002	CcSEcCtD
Doxepin—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000197	CcSEcCtD
Doxepin—Dizziness—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000191	CcSEcCtD
Doxepin—Vomiting—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000183	CcSEcCtD
Doxepin—Rash—Ramipril—type 2 diabetes mellitus	2.26e-05	0.000182	CcSEcCtD
Doxepin—Dermatitis—Ramipril—type 2 diabetes mellitus	2.26e-05	0.000182	CcSEcCtD
Doxepin—Headache—Ramipril—type 2 diabetes mellitus	2.25e-05	0.000181	CcSEcCtD
Doxepin—Imipramine—CYP3A4—type 2 diabetes mellitus	2.18e-05	0.00973	CrCbGaD
Doxepin—Amitriptyline—CYP3A4—type 2 diabetes mellitus	2.16e-05	0.00967	CrCbGaD
Doxepin—Nausea—Ramipril—type 2 diabetes mellitus	2.13e-05	0.000171	CcSEcCtD
Doxepin—Amitriptyline—ALB—type 2 diabetes mellitus	1.89e-05	0.00844	CrCbGaD
Doxepin—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.78e-07	1.22e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	9.77e-07	1.22e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	9.74e-07	1.22e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.72e-07	1.22e-05	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.72e-07	1.22e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.71e-07	1.21e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	9.69e-07	1.21e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.68e-07	1.21e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	9.68e-07	1.21e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	9.68e-07	1.21e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	9.66e-07	1.21e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	9.65e-07	1.21e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.64e-07	1.21e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	9.63e-07	1.2e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	9.63e-07	1.2e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.63e-07	1.2e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	9.62e-07	1.2e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.61e-07	1.2e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	9.6e-07	1.2e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	9.6e-07	1.2e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.6e-07	1.2e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.57e-07	1.2e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.55e-07	1.2e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	9.54e-07	1.19e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.52e-07	1.19e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	9.51e-07	1.19e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.5e-07	1.19e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	9.48e-07	1.19e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.45e-07	1.18e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.42e-07	1.18e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.4e-07	1.18e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.36e-07	1.17e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.36e-07	1.17e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	9.35e-07	1.17e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.27e-07	1.16e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.24e-07	1.16e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	9.23e-07	1.15e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	9.22e-07	1.15e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.22e-07	1.15e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.15e-07	1.14e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	9.12e-07	1.14e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.1e-07	1.14e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	9.04e-07	1.13e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.03e-07	1.13e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9e-07	1.13e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	9e-07	1.13e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.97e-07	1.12e-05	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.96e-07	1.12e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.89e-07	1.11e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.88e-07	1.11e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	8.86e-07	1.11e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.86e-07	1.11e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	8.83e-07	1.1e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.82e-07	1.1e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.82e-07	1.1e-05	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.82e-07	1.1e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	8.81e-07	1.1e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.81e-07	1.1e-05	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.8e-07	1.1e-05	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.77e-07	1.1e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	8.76e-07	1.1e-05	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.74e-07	1.09e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.73e-07	1.09e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.72e-07	1.09e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	8.69e-07	1.09e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.69e-07	1.09e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.68e-07	1.09e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.66e-07	1.08e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.66e-07	1.08e-05	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.66e-07	1.08e-05	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.63e-07	1.08e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.63e-07	1.08e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.6e-07	1.08e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.58e-07	1.07e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.58e-07	1.07e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.55e-07	1.07e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.53e-07	1.07e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	8.52e-07	1.07e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.52e-07	1.07e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.5e-07	1.06e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	8.48e-07	1.06e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	8.42e-07	1.05e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	8.41e-07	1.05e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	8.39e-07	1.05e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.39e-07	1.05e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.34e-07	1.04e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	8.34e-07	1.04e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	8.32e-07	1.04e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	8.3e-07	1.04e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.3e-07	1.04e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.3e-07	1.04e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	8.29e-07	1.04e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	8.28e-07	1.04e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.25e-07	1.03e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	8.25e-07	1.03e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	8.25e-07	1.03e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.24e-07	1.03e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.21e-07	1.03e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	8.19e-07	1.02e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.18e-07	1.02e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.17e-07	1.02e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.17e-07	1.02e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.16e-07	1.02e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	8.15e-07	1.02e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.15e-07	1.02e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.14e-07	1.02e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.12e-07	1.02e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.1e-07	1.01e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.1e-07	1.01e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	8.09e-07	1.01e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.08e-07	1.01e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.02e-07	1e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.02e-07	1e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	8.02e-07	1e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.01e-07	1e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	8e-07	1e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8e-07	1e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.99e-07	9.99e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.96e-07	9.96e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	7.95e-07	9.95e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.95e-07	9.94e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.94e-07	9.93e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	7.93e-07	9.92e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	7.93e-07	9.92e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.89e-07	9.87e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.87e-07	9.85e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.86e-07	9.83e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.84e-07	9.8e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.83e-07	9.8e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	7.74e-07	9.68e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.74e-07	9.68e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	7.74e-07	9.68e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.73e-07	9.67e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.72e-07	9.66e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.68e-07	9.61e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	7.62e-07	9.54e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.62e-07	9.53e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.61e-07	9.52e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	7.59e-07	9.5e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.59e-07	9.5e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.57e-07	9.47e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	7.56e-07	9.46e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	7.56e-07	9.46e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	7.54e-07	9.44e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.53e-07	9.42e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.51e-07	9.39e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.5e-07	9.38e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	7.47e-07	9.35e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.47e-07	9.34e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.45e-07	9.32e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	7.43e-07	9.3e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.43e-07	9.29e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.41e-07	9.27e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	7.41e-07	9.27e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.4e-07	9.25e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.39e-07	9.25e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.37e-07	9.22e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.35e-07	9.2e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.35e-07	9.19e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.32e-07	9.15e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	7.29e-07	9.12e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	7.29e-07	9.12e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.28e-07	9.11e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.28e-07	9.1e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.26e-07	9.08e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	7.25e-07	9.07e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	7.24e-07	9.06e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	7.23e-07	9.04e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	7.23e-07	9.04e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	7.22e-07	9.03e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	7.18e-07	8.99e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	7.12e-07	8.91e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	7.08e-07	8.85e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	7.05e-07	8.81e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.98e-07	8.73e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	6.92e-07	8.66e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.91e-07	8.65e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	6.84e-07	8.55e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	6.81e-07	8.52e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.8e-07	8.51e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.79e-07	8.49e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.78e-07	8.48e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.77e-07	8.46e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.75e-07	8.44e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.74e-07	8.44e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.74e-07	8.43e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	6.71e-07	8.39e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.68e-07	8.36e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.68e-07	8.35e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	6.67e-07	8.34e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.67e-07	8.34e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.66e-07	8.33e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.66e-07	8.32e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.63e-07	8.3e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	6.61e-07	8.27e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.61e-07	8.27e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.55e-07	8.19e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.53e-07	8.17e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	6.5e-07	8.13e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	6.46e-07	8.08e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	6.39e-07	7.99e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	6.37e-07	7.96e-06	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	6.33e-07	7.92e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	6.29e-07	7.87e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.28e-07	7.86e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.19e-07	7.74e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.18e-07	7.73e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	6.18e-07	7.73e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.15e-07	7.69e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.07e-07	7.59e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.93e-07	7.42e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.9e-07	7.38e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.74e-07	7.18e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.67e-07	7.09e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	5.65e-07	7.07e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.65e-07	7.07e-06	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	5.61e-07	7.01e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.54e-07	6.94e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.47e-07	6.85e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.45e-07	6.81e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.44e-07	6.8e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.3e-07	6.63e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.21e-07	6.52e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.21e-07	6.52e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	5.15e-07	6.44e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.13e-07	6.41e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.11e-07	6.4e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.1e-07	6.38e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	5.08e-07	6.36e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.03e-07	6.3e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.02e-07	6.28e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	4.99e-07	6.24e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.81e-07	6.01e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.77e-07	5.96e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.77e-07	5.96e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.73e-07	5.92e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.72e-07	5.9e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.7e-07	5.88e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.69e-07	5.86e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.66e-07	5.83e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.64e-07	5.81e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.63e-07	5.79e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.36e-07	5.46e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.3e-07	5.38e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.65e-07	4.56e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.56e-07	4.45e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.35e-07	4.19e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.32e-07	4.16e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.84e-07	3.55e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.19e-07	2.74e-06	CbGpPWpGaD
